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background: The incidence, timing, and predictors of sudden cardiac death (SCD) in patients (pts) who underwent heart transplantation (HT) are 
unknown.
methods: Adult pts (≥ 18 years) who underwent first time HT in the US between 1987 and 2013 were retrospectively identified from the UNOS 
registry. Pts with “cardiac arrest” as the primary cause of death constituted the SCD group.
results: Data on 37,492 pts (mean age 48.4±13.0 years; 77% males; 78% Caucasian) were analyzed. During a mean follow-up of 6.5±5.7 
years, 17,324 (46.2%) pts died of which 1,659 (9.6%) were SCD (Figure). In multivariate logistic regression analysis (OR; 95% CI), ischemic 
cardiomyopathy as HT indication (1.42; 1.18-1.71), higher donor age per year (1.01; 1.00-1.02), allograft coronary artery disease (CAD) (1.72; 
1.45-2.03), graft rejection (1.67; 1.41-1.99), and left ventricular ejection fraction (LVEF) <40% (2.98; 2.46-3.61) were associated with a higher 
incidence of SCD (all p<0.02). Conversely, Caucasian race (0.66; 0.55-0.91), higher recipient age per year (0.97; 0.96-0.98), and use of ventricular 
assist device prior to HT (0.73; 0.56-0.91) were associated with a lower SCD incidence (all p<0.02). Permanent pacemaker implantation after HT, 
which was associated with longer survival in prior reports, did not reduce SCD (p=0.5)
conclusion: The incidence of SCD after HT is significantly lower than non-SCD. Rejection, allograft CAD, and LVEF <40% are strong predictors of 
SCD in HT pts.
 
